Literature DB >> 12444154

Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge.

Lin Ying Liu1, Julie B Sedgwick, Mary Ellen Bates, Rose F Vrtis, James E Gern, Hirohita Kita, Nizar N Jarjour, William W Busse, Elizabeth A B Kelly.   

Abstract

IL-5 is a key cytokine for eosinophil maturation, recruitment, activation, and possibly the development of inflammation in asthma. High concentrations of IL-5 are present in the airway after Ag challenge, but the responsiveness of airway eosinophils to IL-5 is not well characterized. The objectives of this study were to establish, following airway Ag challenge: 1) the expression of membrane (m)IL-5Ralpha on bronchoalveolar lavage (BAL) eosinophils; 2) the responsiveness of these cells to exogenous IL-5; and 3) the presence of soluble (s)IL-5Ralpha in BAL fluid. To accomplish these goals, blood and BAL eosinophils were obtained from atopic subjects 48 h after segmental bronchoprovocation with Ag. There was a striking reduction in mIL-5Ralpha on airway eosinophils compared with circulating cells. Furthermore, sIL-5Ralpha concentrations were elevated in BAL fluid, but steady state levels of sIL-5Ralpha mRNA were not increased in BAL compared with blood eosinophils. Finally, BAL eosinophils were refractory to IL-5 for ex vivo degranulation, suggesting that the reduction in mIL-5Ralpha on BAL eosinophils may regulate IL-5-mediated eosinophil functions. Together, the loss of mIL-5Ralpha, the presence of sIL-5Ralpha, and the blunted functional response (degranulation) of eosinophils to IL-5 suggest that when eosinophils are recruited to the airway, regulation of their functions becomes IL-5 independent. These observations provide a potential explanation for the inability of anti-IL-5 therapy to suppress airway hyperresponsiveness to inhaled Ag, despite a reduction in eosinophil recruitment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444154     DOI: 10.4049/jimmunol.169.11.6452

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.

Authors:  Stephane Esnault; Elizabeth A B Kelly; Zhong-Jian Shen; Mats W Johansson; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

2.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.

Authors:  Anne M Brooks; Mary Ellen Bates; Rose F Vrtis; Nizar N Jarjour; Paul J Bertics; Julie B Sedgwick
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-25       Impact factor: 6.914

3.  Human Eosinophils Express a Distinct Gene Expression Program in Response to IL-3 Compared with Common β-Chain Cytokines IL-5 and GM-CSF.

Authors:  Ryan K Nelson; Howard Brickner; Bharat Panwar; Ciro Ramírez-Suástegui; Sara Herrera-de la Mata; Neiman Liu; Damaris Diaz; Laura E Crotty Alexander; Ferhat Ay; Pandurangan Vijayanand; Grégory Seumois; Praveen Akuthota
Journal:  J Immunol       Date:  2019-06-07       Impact factor: 5.422

Review 4.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

5.  Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.

Authors:  Whitney W Stevens; Christopher J Ocampo; Sergejs Berdnikovs; Masafumi Sakashita; Mahboobeh Mahdavinia; Lydia Suh; Tetsuji Takabayashi; James E Norton; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Atsushi Kato; Kathleen E Harris; Roderick G Carter; Shigeharu Fujieda; Robert C Kern; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

6.  Systemic eosinophil response induced by respiratory syncytial virus.

Authors:  C A Lindemans; J L L Kimpen; B Luijk; J Heidema; D Kanters; C K van der Ent; L Koenderman
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

7.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Authors:  Elizabeth A Kelly; Stephane Esnault; Lin Ying Liu; Michael D Evans; Mats W Johansson; Sameer Mathur; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

8.  Role of insulin-like growth factor binding protein-3 in allergic airway remodeling.

Authors:  Kristen L Veraldi; Bethany T Gibson; Hidekata Yasuoka; Michael M Myerburg; Elizabeth A Kelly; Silvana Balzar; Nizar N Jarjour; Joseph M Pilewski; Sally E Wenzel; Carol A Feghali-Bostwick
Journal:  Am J Respir Crit Care Med       Date:  2009-07-16       Impact factor: 21.405

9.  Allergy, asthma, and inflammation: which inflammatory cell type is more important?

Authors:  Redwan Moqbel; Solomon O Odemuyiwa
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

10.  The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation.

Authors:  Zhong-Jian Shen; Stephane Esnault; Anna Schinzel; Christoph Borner; James S Malter
Journal:  Nat Immunol       Date:  2009-02-01       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.